| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
15,830,000 |
| Market
Cap: |
33.88(M) |
| Last
Volume: |
86,028 |
Avg
Vol: |
76,335 |
| 52
Week Range: |
$1.69 - $11.04 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inotiv is a contract research organization providing drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. Co.'s segments include: contract research services, which provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing; and research products, which designs, develops, manufactures and markets in vivo sampling systems and accessories, physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
52,966 |
52,966 |
72,966 |
| Total Buy Value |
$0 |
$163,981 |
$163,981 |
$445,856 |
| Total People Bought |
0 |
2 |
2 |
3 |
| Total Buy Transactions |
0 |
2 |
2 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
5,123 |
| Total Sell Value |
$0 |
$0 |
$0 |
$58,709 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leasure Robert Jr. |
President and CEO |
• • – |
2022-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
42,429 |
280,216 |
|
- |
|
| Downing Philip A |
Sr. VP, Preclinical Srvcs. |
• – – |
2021-12-22 |
4 |
S |
$43.04 |
$131,577 |
D/D |
(3,057) |
40,195 |
|
67% |
|
| Taylor Beth |
VP- Finance & CFO |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
214 |
38,875 |
|
- |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
299 |
42,674 |
|
- |
|
| Jermyn Street Associates Llc |
|
• • • |
2021-11-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(35,512) |
7,156 |
|
- |
|
| Jermyn Street Associates Llc |
|
• • • |
2021-11-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(359,033) |
2,294,946 |
|
- |
|
| Cragg Scott |
Director |
– • – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
I/I |
378,984 |
499,095 |
|
- |
|
| Cragg Scott |
Director |
– • – |
2021-11-05 |
4/A |
A |
$0.00 |
$0 |
I/I |
120,111 |
120,111 |
|
- |
|
| Jermyn Street Associates Llc |
|
– – • |
2021-11-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,698,647 |
|
-58% |
|
| Moller Claus J |
10% Owner |
– – • |
2021-11-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,946,961 |
|
-58% |
|
| Bibi Mark L |
General Counsel and Secretary |
• – – |
2021-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
58,134 |
58,134 |
|
- |
|
| Brown Nigel |
Director |
– • – |
2021-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
440 |
|
- |
|
| Cragg Scott |
Director |
– • • |
2021-11-05 |
4 |
A |
$0.00 |
$0 |
I/I |
487,913 |
9,515 |
|
- |
|
| Cragg Scott |
Director |
– • • |
2021-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
440 |
|
- |
|
| Downing Philip A |
Sr. VP, Preclinical Srvcs. |
• – – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,087 |
43,252 |
|
- |
|
| Beattie John Gregory |
Chief Operating Officer |
• – – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
954 |
31,394 |
|
- |
|
| Leasure Robert Jr. |
President and CEO |
• • – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
7,571 |
237,787 |
|
- |
|
| Taylor Beth |
VP- Finance & CFO |
• – – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,332 |
38,661 |
|
- |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2021-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
454 |
42,375 |
|
- |
|
| Johnson Richard Allen |
Director |
– • – |
2021-08-02 |
4 |
OE |
$0.86 |
$32,300 |
D/D |
25,000 |
67,683 |
|
- |
|
| Sagartz John E |
Chief Strategy Officer |
• • – |
2021-06-07 |
4 |
B |
$28.70 |
$49,995 |
D/D |
1,742 |
648,524 |
2.81 |
23% |
|
| Sagartz John E |
Chief Strategy Officer |
• • – |
2021-05-28 |
4 |
B |
$24.78 |
$49,857 |
D/D |
2,012 |
646,782 |
2.81 |
27% |
|
| Sagartz John E |
Chief Strategy Officer |
• • – |
2021-05-27 |
4 |
B |
$24.00 |
$120 |
D/D |
5 |
644,770 |
2.73 |
26% |
|
| Taylor Beth |
VP- Finance & CFO |
• – – |
2021-05-13 |
4 |
B |
$23.14 |
$49,844 |
D/D |
2,154 |
37,329 |
2.74 |
50% |
|
| Pitchford William D |
Chief HR Officer |
• – – |
2021-05-13 |
4 |
B |
$23.72 |
$35,580 |
D/D |
1,500 |
41,921 |
2.74 |
50% |
|
243 Records found
|
|
Page 3 of 10 |
|
|
0.10 (4.46%) 
